The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization-Reference-Cited by-同舟云学术

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization

Published:2012-04-11 Issue:4 Volume:7 Page:e29454
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Brown Bruce K.,Wieczorek Lindsay,Kijak Gustavo,Lombardi Kara,Currier Jeffrey,Wesberry Maggie,Kappes John C.,Ngauy Viseth,Marovich Mary,Michael Nelson,Ochsenbauer Christina,Montefiori David C.,Polonis Victoria R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.;S Rerks-Ngarm;N Engl J Med,2009

2. A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160 (92TH023/LAI-DID) or Bivalent gp120 (CM235/SF2) Boost.;P Thongcharoen;J Acquir Immune Defic Syndr,2007

3. Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.;P Pitisuttithum;J Acquir Immune Defic Syndr,2004

4. Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.;P Pitisuttithum;J Infect Dis,2003

5. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?;L Stamatatos;Nat Med,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations;Vaccines;2017-08-09

2. Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers;AIDS Research and Human Retroviruses;2017-08

3. Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene;Journal of Infectious Diseases;2016-02-11

4. Optimized ReplicatingRenillaLuciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function;AIDS Research and Human Retroviruses;2015-12

5. Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research;Journal of Virology;2015-08